Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
Article in Clinical and Translational Medicine (June 2022)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Clinical and Translational Medicine (June 2022)
Article in Cell Death & Disease (March 2022)
Article in Open Medicine (January 2022)